Invicta Diagnostic bulk deals
NSE: INVICTAHealthcare Services
Last close ₹60.50down ₹4.20 (6.49%)
Share price at the NSE close on 23 Oct 2026. Previous close ₹64.70.
Range of traded prices from listing on 8 Dec 2025 to 23 Oct 2026
₹58.10Low, 5 Mar 2026₹105.00High, 8 Dec 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price.
- ₹76 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 18 May 2026
- 15.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 18 May 2026
- 1.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Dec 2025
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 18 May 2026
- 9.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 18 May 2026
- 12.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 18 May 2026
- 0.07
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 8,000100.0% delivered
Invicta Diagnostic bulk deals
Last 12 months, since 23 Oct 2025: 13 bulk deals, ₹14 Cr bought and ₹5.00 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Wednesday 5 Aug 20262 firms · ₹1.43 Cr bought · ₹1.43 Cr soldNet nil
- BoughtBIRCHWOOD MULTI STGY FND OPENENDED PCC LTD - BIRCHWOOD GLOBAL ALPHA FUNDBought 1,93,600 at ₹73.791.54% of the company₹1.43 Cr
- SoldPINE OAK GLOBAL FUNDSold 1,93,600 at ₹73.791.54% of the company₹1.43 Cr
Tuesday 5 May 20262 firms · ₹0.68 Cr bought · ₹0.68 Cr soldNet nil
- BoughtINFINITY INVESTORS INDIABought 70,400 at ₹95.950.56% of the company₹0.68 Cr
- SoldPINE OAK GLOBAL FUNDSold 70,400 at ₹95.950.56% of the company₹0.68 Cr
Friday 27 Mar 20261 firm · ₹0.56 Cr bought · ₹0 soldNet bought ₹0.56 Cr
- BoughtRGSL INVESTMENT LVF 1Bought 84,800 at ₹66.000.67% of the company₹0.56 Cr
Monday 23 Mar 20261 firm · ₹0.82 Cr bought · ₹0 soldNet bought ₹0.82 Cr
- BoughtRGSL INVESTMENT LVF 1Bought 1,21,600 at ₹67.500.97% of the company₹0.82 Cr
Thursday 19 Mar 20262 firms · ₹1.14 Cr bought · ₹0.88 Cr soldNet bought ₹0.27 Cr
- BoughtNIHAR AMIT DAVEBought 1,50,400 at ₹76.001.20% of the company₹1.14 Cr
- SoldNEERAJ VISHNUKUMAR GUPTASold 1,15,200 at ₹76.000.92% of the company₹0.88 Cr
Thursday 5 Mar 20261 firm · ₹0.85 Cr bought · ₹0 soldNet bought ₹0.85 Cr
- BoughtINVESTI GLOBAL OPPORTUNITY FUND PCC - CELL 1Bought 1,20,000 at ₹70.440.95% of the company₹0.85 Cr
Thursday 12 Feb 20262 firms · ₹1.10 Cr bought · ₹1.10 Cr soldNet nil
- SoldNEERAJ VISHNUKUMAR GUPTASold 1,60,000 at ₹69.001.27% of the company₹1.10 Cr
- BoughtPINE OAK GLOBAL FUNDBought 1,60,000 at ₹69.001.27% of the company₹1.10 Cr
Monday 19 Jan 20262 firms · ₹1.13 Cr bought · ₹0.91 Cr soldNet bought ₹0.22 Cr
- BoughtNIHAR AMIT DAVEBought 1,48,800 at ₹75.801.18% of the company₹1.13 Cr
- SoldLAXMI TRADING & INVESTMENTSSold 1,20,000 at ₹76.000.95% of the company₹0.91 Cr
Monday 8 Dec 20253 firms · ₹6.76 Cr bought · ₹0 soldNet bought ₹6.76 Cr
- BoughtNEERAJ VISHNUKUMAR GUPTABought 2,99,200 at ₹98.342.38% of the company₹2.94 Cr
- BoughtLAXMI TRADING & INVESTMENTSBought 2,03,200 at ₹98.071.62% of the company₹1.99 Cr
- BoughtPINE OAK GLOBAL FUNDBought 1,82,400 at ₹100.001.45% of the company₹1.82 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 13 deals on record since listing on 8 Dec 2025.